Forma Therapeutics Holdings, Inc. Common Stock
FMTX
FMTX was delisted on the 13th of October, 2022.
93 hedge funds and large institutions have $1.29B invested in Forma Therapeutics Holdings, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 33 increasing their positions, 9 reducing their positions, and 4 closing their positions.
850% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 4
267% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 9
58% more funds holding
Funds holding: 59 → 93 (+34)
12.25% more ownership
Funds ownership: 67.37% → 79.62% (+12%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
6% less capital invested
Capital invested by funds: $1.38B → $1.29B (-$85.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$100M |
| 2 |
BlackRock
New York
|
+$51.2M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$47M |
| 4 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
+$34.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$28.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$15.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$15.1M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$5.21M |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$3.21M |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$725K |
FMTX Hedge Fund Activity: Q4 2020 in Review
93 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q4 2020, worth a combined $1.29B — down 6.2% from $1.38B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new FMTX positions and 4 closed out — a net gain of 34 holders — while 33 added to existing stakes and 9 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $100M. The largest seller was Janus Henderson Group, cutting an estimated $15.9M.
- 93 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q4 2020, up from 59 in Q3 2020.
- Funds reported $1.29B of Forma Therapeutics Holdings, Inc. Common Stock stock for Q4 2020, down 6.2% quarter-over-quarter.
- 38 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q4 2020 and 4 closed out, a net change of +34 holders.
- The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q4 2020 was Fidelity Investments, an estimated $100M added.
- The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q4 2020 was Janus Henderson Group, an estimated $15.9M sold.
Based on aggregated 13F filings for Q4 2020.